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Abstract (J Korean Assoc Oral Maxillofac Surg 2012;38:240-4)
Myofibroblastic sarcoma is a rare tumor that mostly develops in the soft tissues of the head and neck. Within the oral cavity, a tongue lesion is the most 
common. A myofibroblastic sarcoma tends to recur locally instead of metastasizing. We encountered a myofibroblastic sarcoma of the mandible of a 
9-year-old male and performed mass excision and additional marginal alveolectomy. So far, there is neither recurrence nor metastasis. We report this 
case because of the uncommon location of this tumor type and its surgical approach compared to other forms of sarcomas. 
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approach	compared	to	other	forms	of	sarcoma.
II. Case Report
In	December	2010,	a	9-year-old	male	patient	visited	us	due	
to	the	painless	soft	tissue	lesion	in	the	right	mandible,	which	
he	felt	starting	a	month	earlier	when	he	received	excisional	
biopsy	of	 the	 lesion	 in	 the	mandible	by	a	dentist	and	got	
diagnosed	with	pyogenic	granuloma.	Two	weeks	after	 the	
excisional	biopsy,	however,	it	recurred;	thus,	the	patient	was	
referred	to	us	after	he	received	excision	biopsy	again	and	was	
finally	diagnosed	with	myofibroblastic	sarcoma.	
In	the	clinical	examination	performed	on	the	day	of	 the	
first	visit,	a	3×2	cm	reddish	lesion	with	relatively	distinct	
boundary	evaginated	to	the	right	lingual	side	of	the	mandible	
was	identified;	the	surface	was	covered	with	inflammatory	
granulation	tissues,	and	it	had	easy	bleeding	tendency.	An	
ulcer	was	identified	on	some	part	of	 the	surface	of	lesion.
(Fig.	1)	#46,	84,	 and	85	adjacent	 to	 the	 lesion	 showed	
medium	level	of	mobility	laterally	and	vertically	when	the	
wire	 fixation	placed	by	 the	dentist	was	 removed.	 In	 the	
examination	by	touch,	the	lesion	was	found	to	extend	into	
the	mandible.	Though	the	patient	experienced	inconvenience,	
there	were	no	spontaneous	pain	and	significant	paresthesia	
in	 the	 lower	 teeth,	 lower	 lip,	and	chin.	 In	 the	panoramic	
radiographs,	on	the	#46,	85	apical	area,	osteolytic	lesion	with	
relatively	distinct	boundary	was	observed,	including	invasion	
of	lesion	on	top	of	#45	tooth	germs.(Fig.	2)	The	computed	
I. Introduction
In	the	head	and	neck,	epithelial	malignant	tumors	account	
for	at	 least	80%,	and	mesodermal	malignant	 tumors	are	
relatively	infrequent1.	Among	mesodermal	malignant	tumors,	
myofibroblastic	sarcoma	is	a	very	rare	disease	that	can	occur	
in	most	organs	 including	skin,	 limbs,	abdominal	cavity,	
pelvic	cavity,	thoracic	cavity,	and	diaphragm	but	generally	
afflicts	the	head	and	neck	such	as	tongue,	floor	of	the	mouth,	
pharynx,	larynx,	parapharyngeal	space,	salivary	gland,	and	
maxillary	bones2-6.	Within	the	oral	cavity,	tongue	lesion	is	the	
most	common.	Though	the	treatment	has	yet	to	be	established	
clearly	due	to	the	low	incidence,	treatment	plans	including	
the	extent	of	surgical	excision	are	determined	considering	the	
grade	of	malignancy,	size	and	location	of	lesion,	age	of	the	
patient,	 invasion	into	adjacent	tissues,	and	metastasis	after	
biopsy	due	to	various	grades	of	malignancy7.	We	encountered	
a	case	of	myofibroblastic	sarcoma	of	 the	mandible	with	a	
9-year-old	male,	and	we	are	reporting	this	case	because	of	
the	uncommon	location	of	this	tumor	type	and	its	surgical	
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part	of	the	lesion.	Nonetheless,	the	tumor	was	deemed	to	have	
been	removed	completely	because	additional	alveolectomy	
was	performed	simultaneously	on	the	lower	part	of	the	lesion.	
Though	the	patient	experienced	temporary	paresthesia	in	the	
right	lower	lip	and	chin	after	the	surgery,	after	3	months	the	
patient	was	restored	and	cured	without	complications	such	as	
inflammation	or	infection.
In	the	histological	examination,	 thin	and	spindle-shaped	
myofibroblasts	were	intersected	with	each	other,	 invading	
the	surrounding	tissues	locally.	Most	myofibroblasts	had	a	
spindle-shaped	core,	but	some	had	a	circle	or	a	pleomorphic	
core	and	showed	partial	hyperchromatism.	Though	some	
pleomorphic	 cells	 showed	high-grade	dysplasia,	most	
myofibroblasts	exhibited	low-grade	dysplasia	without	tissue	
necrosis.	Blood	circulation	in	the	surrounding	area	was	more	
tomography	(CT)	and	magnetic	resonance	imaging	(MRI)	
revealed	a	 lesion	with	relatively	distinct	boundary	 in	 the	
mandible	destroying	the	lingual	cortical	bone	and	extending	
to	the	inside	of	the	mandible	without	invading	adjacent	areas	
such	as	floor	of	 the	mouth,	sublingual	space,	and	tongue.	
There	was	no	lymph	node	metastasis.(Fig.	3)
On	December	31,	2010,	the	patient	underwent	mass	excision	
including	extraction	of	#84,	85,	44,	45,	46,	and	47	and	
alveolectomy	on	the	lower	part	of	the	lesion	under	general	
anesthesia.(Fig.	4)	The	resected	soft	mass	measured	3×2.5	cm	
and	was	easily	divided	from	the	surrounding	tissues;	in	the	
final	biopsy,	however,	tumor	cells	were	detected	on	the	lower	
Fig. 1. Intraoral view of soft tissue mass on the lingual side of the 
mandible showing granulomatous tissue overgrowth.
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Fig. 2. Initial panoramic view showing radiolucent lesion on #85, 
46 apical area with loss of crypt wall of #45.
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Fig. 3. Radiographic findings of myofibroblastic sarcoma. A. Computed tomography showing osteolytic lesion in the right mandible with 
cortical destruction on the lingual side. B, C. Magnetic resonance imaging showing 2.5 cm enhancing mass arising from the right mandible 
with extra-mandibular extension; no gross invasion in the floor of the mouth, tongue, and right sublingual space, with no pathological 
lymph nodes.
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III. Discussion
Myofibroblast	is	a	cell	in	the	intermediate	stage	of	fibro-
blast’s	myogenesis	process.	It	is	located	in	the	soft	tissues	
of	most	organs6.	During	the	treatment	of	wound	or	reaction	
of	 responsive	cells,	 temporary	 fibroblasts	are	observed,	
but	 they	die	by	apoptosis	when	the	 treatment	 is	 finished.	
If	 there	 is	a	problem	in	 this	process,	 they	become	tumor	
cells.	The	reason	and	phenomenological	 interpretation	of	
the	myofibro	blast’s	differentiation	into	tumor	cell	have	not	
been	discovered	despite	the	many	research	studies,	and	the	
than	sufficient,	and	mitotic	 index	was	relatively	 low	at	5	
mitotic	figures	per	10	high-power	fields.(Fig.	5)	Moreover,	
myofibroblast	 tested	positive	 for	 immunohistochemical	
staining	with	CD34.	Considering	the	histological,	clinical,	
and	radiological	opinions,	 the	patient	was	diagnosed	with	
pT1N0M0,	 stage	 I,	 low-grade	myofibroblastic	 sarcoma	
(LGMS)	in	the	mandible.
The	patient	did	not	receive	additional	treatments	including	
radiation	and	anticancer	treatments;	 three	months	after	the	
surgery,	 removable	denture	was	placed	 in	 the	edentulous	
area.	Eighteen	months	after	 the	surgery,	 there	was	neither	
recurrence	nor	distant	metastasis.(Fig.	6)	The	patient	has	
been	examined	regularly	by	the	Department	of	Pediatrics,	
Fig. 4. Resected specimen showing well-encapsulated mass. A. Buccal side view. B. Lower part side view.
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Fig. 5. Histological findings of myofibroblastic sarcoma. A. Microscopic appearance showing streaming fascicles of spindle-shaped and 
stellate myofibroblasts exhibiting pleomorphism (H&E staining, ×200). B. Immunohistochemical staining with CD34 (×100).
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power	fields),	and	partial	tissue	necrosis12.	If	the	diagnosis	
is	high	grade	after	surgical	excision,	radiation	treatment	is	
generally	recommended,	and	anticancer	 treatment	may	be	
used	in	combination	 in	case	of	high	possibility	of	distant	
metastasis11.	Fisher	reported	 that,	out	of	39	LGMS	cases,	
13	patients	 (33%)	experienced	partial	 recurrence	and	3	
patients	(8%)	had	distant	metastasis,	and	that,	out	of	22	cases	
of	high-grade	myofibroblastic	sarcoma,	7	patients	 (32%)	
experienced	partial	 recurrence	and	15	patients	(68%)	had	
distant	metastasis10.	According	to	Mentzel	et	al.7,	out	of	18	
LGMS	cases,	2	patients	experienced	recurrence,	1	patient	had	
metastasis,	14	patients	received	surgical	excision,	and	4	other	
patients	received	surgical	excision	and	additional	treatments	
such	as	radiation	and	anticancer	treatments.
Given	the	variety	of	existing	treatments	and	clinical	results	
of	myofibroblastic	sarcoma,	histopathological	evaluation	
and	clinical/radiographic	determinations	are	very	important	
factors	of	prognosis.	In	particular,	for	children	patients	such	
as	the	patient	in	this	case,	deciding	the	proper	surgical	margin	
is	critical	while	minimizing	problems	in	the	mandibular	bone.	
In	this	case,	we	were	able	to	obtain	a	successful	treatment	
result	by	performing	only	alveolectomy	covering	the	lesion	
while	minimizing	problems	in	the	growth	and	development	
of	mandible,	considering	the	facts	that	the	lesion	had	distinct	
boundaries,	 there	was	no	 invasion	 into	 the	 surrounding	
tissues	except	 the	 lingual	 side	of	 the	mandible	and	#45	
permanent	tooth	germs,	the	patient	was	young	and	he	had	low	
pathological	grade,	and	the	lesion	tended	to	show	more	local	
recurrence	than	metastasis.	Nonetheless,	the	most	important	
thing	is	to	secure	a	clean	surgical	margin,	and	there	is	a	need	
to	check	for	recurrence	through	long-term	observation.	
treatment	method	for	myofibroblastic	sarcoma	has	yet	 to	
be	established7.	This	 is	because	there	are	not	enough	case	
reports,	myofibroblast	has	various	and	complex	histological	
differentiations	and	grades	of	malignancy,	and	its	prognosis	
can	change	according	 to	 the	 location	and	size	of	 lesion8.	
In	existing	research,	high-grade	myofibroblastic	sarcoma	
is	aggressive,	showing	more	distant	metastasis	 than	 local	
recurrence.	LGMS,	however,	shows	more	local	recurrence	
than	distant	metastasis	and	tends	to	invade	into	soft	tissues8-10.	
LGMS	occurs	2.5	 times	more	frequently	 in	males	 than	
females,	generally	afflicting	soft	tissue,	fascia,	and	subcutan-
eous	tissues	such	as	head	and	neck,	limbs,	pelvis,	lung,	chest,	
abdomen,	genitals,	diaphragm,	thyroid,	and	skin.	Within	the	
head	and	neck,	tongue	lesion	is	the	most	common	followed	
by	salivary	gland,	floor	of	the	mouth,	parapharyngeal	space,	
and	occipital	area2,3,5-7,9.	Mandibular	lesion	is	an	extremely	
rare	lesion	even	for	LGMS.	Generally	occurring	in	the	tongue,	
it	is	felt	by	the	patient	after	the	size	of	the	lesion	increases	
without	clinical	symptom	or	pain,	showing	distinct	boundaries	
in	radiological	images	and	exhibiting	osteoclasia	and	invasion	
on	some	boundaries.	This	case	has	similar	aspects4.
For	general	sarcoma,	extensive	2-5	cm	excision	is	per	for-
med,	but	the	range	of	surgical	excision	for	LGMS	is	deter-
mined	considering	 the	clinical	decisions	and	histological	
opinions	of	the	operator11.	Therefore,	the	range	of	excision	
may	be	determined	according	 to	 the	age	of	 the	patient,	
size	and	location	of	lesion,	destruction	of	adjacent	tissues,	
metastasis,	and	histological	grade	of	malignancy.	Generally,	
the	diagnosis	 is	high	grade	when	combining	size	 larger	
than	10	cm,	deep	location,	high	histological	grade	of	malig-
nancy	(high	mitotic	index	>10	mitotic	figures	per	10	high-
Fig. 6. Post-operative panoramic X-ray (A) and clinical photo (B) after 18 months.
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